Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

Christos A Venetis^{1

2

3}, Christoph Helwig⁴, Ben W Mol⁵, Su Jen Chua⁶, Salvatore Longobardi⁷, Raoul Orvieto^{8

9}, Monica Lispi^{10

11}, Ashleigh Storr^{12

13}, Thomas D'Hooghe^{11

14

15}

Affiliations

¹ Unit for Human Reproduction, 1st Dept of OB/Gyn, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Centre for Big Data Research in Health, University of New South Wales, Kensington Campus, New South Wales, Australia.
³ IVF Australia, Sydney, NSW, 2000, Australia.
⁴ Global Biostatistics, Merck KGaA, Darmstadt, Germany.
⁵ Department of Obstetrics and Gynecology, University of Monash, Monash, Clayton, Victoria, 3168, Australia. ben.mol@monash.edu.
⁶ Alfred Health, Melbourne, VIC, 3004, Australia.
⁷ Global Clinical Development, Merck Serono S.p.A (an affiliate of Merck KGaA, Darmstadt 64293, Germany), Rome, 00176, Italy.
⁸ Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 52621, Israel.
⁹ The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, 6997801, Israel.
¹⁰ University of Modena and Reggio Emilia, Modena, MO, 41121, Italy.
¹¹ GlobalMedical Affairs Fertility, Research and Development, Merck KGaA, F135/002, Darmstadt, 64293, Germany.
¹² Flinders Fertility, Adelaide, South Australia, 5045, Australia.
¹³ College of Medicine and Public Health, Flinders University, Adelaide, South Australia, 5042, Australia.
¹⁴ Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of Leuven), Leuven, 3000, Belgium.
¹⁵ Department of Obstetrics and Gynecology, Yale University, New Haven, CT, 06510, USA.

PMID: 37496043
PMCID: PMC10369731
DOI: 10.1186/s12958-023-01114-5

Published Erratum

Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

Christos A Venetis et al. Reprod Biol Endocrinol. 2023.

. 2023 Jul 26;21(1):68.

doi: 10.1186/s12958-023-01114-5.

Authors

Affiliations

¹ Unit for Human Reproduction, 1st Dept of OB/Gyn, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Centre for Big Data Research in Health, University of New South Wales, Kensington Campus, New South Wales, Australia.
³ IVF Australia, Sydney, NSW, 2000, Australia.
⁴ Global Biostatistics, Merck KGaA, Darmstadt, Germany.
⁵ Department of Obstetrics and Gynecology, University of Monash, Monash, Clayton, Victoria, 3168, Australia. ben.mol@monash.edu.
⁶ Alfred Health, Melbourne, VIC, 3004, Australia.
⁷ Global Clinical Development, Merck Serono S.p.A (an affiliate of Merck KGaA, Darmstadt 64293, Germany), Rome, 00176, Italy.
⁸ Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 52621, Israel.
⁹ The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, 6997801, Israel.
¹⁰ University of Modena and Reggio Emilia, Modena, MO, 41121, Italy.
¹¹ GlobalMedical Affairs Fertility, Research and Development, Merck KGaA, F135/002, Darmstadt, 64293, Germany.
¹² Flinders Fertility, Adelaide, South Australia, 5045, Australia.
¹³ College of Medicine and Public Health, Flinders University, Adelaide, South Australia, 5042, Australia.
¹⁴ Research Group Reproductive Medicine, Department of Development and Regeneration, Organ Systems, Group Biomedical Sciences, KU Leuven (University of Leuven), Leuven, 3000, Belgium.
¹⁵ Department of Obstetrics and Gynecology, Yale University, New Haven, CT, 06510, USA.

PMID: 37496043
PMCID: PMC10369731
DOI: 10.1186/s12958-023-01114-5

No abstract available

PubMed Disclaimer

Figures

**Fig. 3**
(Corrected Figure 3B) Mean difference number in of oocytes retrieved

See this image and copyright information in PMC

Erratum for

Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis.
Chua SJ, Mol BW, Longobardi S, Orvieto R, Venetis CA, Lispi M, Storr A, D'Hooghe T. Chua SJ, et al. Reprod Biol Endocrinol. 2021 Apr 2;19(1):51. doi: 10.1186/s12958-021-00727-y. Reprod Biol Endocrinol. 2021. PMID: 33794909 Free PMC article.

References

1. Chua SJ, Mol BW, Longobardi S, et al. Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2021;19:51. doi: 10.1186/s12958-021-00727-y. - DOI - PMC - PubMed
1. Hu L, et al. Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer. Aging (Albany NY) 2020;12(6):4918–4930. doi: 10.18632/aging.102919. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

Affiliations

Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis

Authors

Affiliations

Figures

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources